1.The Role of bcl-2 and p53 in Tamoxifen-Induced Apoptosis of Human Breast Cancer Cell Lines.
Woo Chul NOH ; Dong Young NOH ; Yong Ho HAM ; Chang Min KIM ; Nam Sun PAIK ; Nan Mo MOON ; Kuk Jin CHOE
Journal of the Korean Cancer Association 2000;32(3):531-538
PURPOSE: Tamoxifen has been well known as an effective anti-tumor agent against breast cancer. The important role of bcl-2 and p53 proteins in tamoxifen-induced apoptosis of breast cancer cells has been suggested. However, the paradoxical fact that bcl-2 over-expression is assdegrees Ciated with better prognosis in clinic has not yet been clearly explained. To investigate this paradox, we analyzed the effect and dynamics of bcl-2 and p53 on the apoptosis after treatment of breast cancer cells with tamoxifen. MATERIALS AND METHODS: The human breast cancer cell lines MCF-7 and MB MDA-468 were treated with 17-betaestradiol (E2) and tamoxifen. RESULTS: Following tamoxifen treatment, MCF-7 cells underwent apoptosis accompanied by reduced bcl-2 expression. E2 pre-treatment led to the inhibition of tamoxifen-mediated apoptosis and bcl-2 down-regulation. When MB MDA-468 cells were treated with E2 or tamoxifen, bcl-2 and p53 protein expression did not change and apoptosis did not develop. CONCLUSION: We observed that the down-regulation of bcl-2 by tamoxifen treatment can facilitate the apoptosis of breast cancer cells without p53 mutations. This finding was consistent with clinical experiences in which bcl-2 positive tumors were assdegrees Ciated with more indolent phenotypes in breast cancer.
Apoptosis*
;
Breast Neoplasms*
;
Breast*
;
Cell Line*
;
Down-Regulation
;
Humans*
;
MCF-7 Cells
;
Phenotype
;
Prognosis
;
Tamoxifen
2.A case of hyponatremia as the intial manifestation of Sheehan's syndrome.
Cheul Woo LEE ; Hyun Ju NOH ; Jung Ki MIN ; Eun Young YANG ; Yong Duk SHIN ; Dong Jin KIM
Korean Journal of Obstetrics and Gynecology 2000;43(9):1666-1669
No abstract available.
Hyponatremia*
;
Hypopituitarism*
3.Differential pattern of perivascular type IV collagen deposits in phyllodes tumors of the breast.
Woo Ho KIM ; Chul Woo KIM ; Dong Young NOH ; Yong Il KIM
Journal of Korean Medical Science 1992;7(4):360-363
Deposition of basement membrane extracellular matrix is influenced by adjacent tumor cells, and in some cases, the pattern of type IV collagen deposit is characteristic in malignant tumors. In this report, we analyzed the difference in type IV collagen deposition patterns between benign and malignant phyllodes tumors (PTs) of the breast. Of the 15 cases of PTs, 8 cases were benign PTs and 7 cases were malignant PTs. Three cases of other primary sarcomas of the breast (stromal sarcoma, angiosarcoma and osteosarcoma) and 2 cases of fibroadenomas were studied for comparison. The malignant PTs were distinguished from benign ones by increased mitotic figures, cellular atypism, and a higher proliferation index of stromal cells. Immunohistochemical staining against type IV collagen in malignant PTs revealed extensive to moderate deposition of type IV collagen around the small blood vessels in duplicate or multilayering pattern, while benign PTs showed minimal deposition in a single linear pattern. All of the three cases of other sarcomas revealed multilayering or meshwork pattern of type IV collagen around the blood vessels. The deposition of type IV collagen around the blood vessels may reflect the malignant behavior of the stromal tumors of the breast.
Adult
;
Breast Neoplasms/blood supply/*metabolism
;
Collagen/*metabolism
;
Female
;
Humans
;
Middle Aged
;
Retrospective Studies
4.Correlation of c-erbB-2 protein overexpression in human breast carcinoma with nodal status, tumor size, stage, age and survival.
Byung Sik KIM ; Dong Young NOH ; Kak Jin CHOE ; Kuhn Kuk LEE ; Seong Hoe PARK ; Yong Il KIM ; Joo Bae PARK
Journal of the Korean Cancer Association 1991;23(1):20-28
No abstract available.
Breast Neoplasms*
;
Breast*
;
Humans*
;
Receptor, erbB-2*
5.Expression of aromatase in endometiosis and its relation to clinical laboratory and surgical parameters.
Il Han LEE ; Dong Ho KIM ; Ji Hyun NOH ; Jae Whoan KOH ; Yong Bong KIM
Korean Journal of Obstetrics and Gynecology 2010;53(4):346-353
OBJECTIVE: Aromatase is the key enzyme for the conversion of C19 steroids into estrogen in certain human tissues. We studied to evaluate the aromatase expression in eutopic endometirum and endometriotic lesion and its relationship to clinical and laboratory parameters. METHODS: The study included 78 cases of endometriotic lesion and 14 cases of eutopic endometrium and 30 cases of normal uterine endometrium obtained through laparoscopic surgery and curettage. The frozen tissue specimens were examined by immunohistochemistry using aromatase. Clinical symptoms, laboratory findings, and operative findings were analyzed and compared in according to aromatase expression. RESULTS: We observed positive immunohistochemical expression for aromatase in endometriotic lesion from 46/78 patients (59.0%). Aromatase expression was elevated in comparison to eutopic endometrium (5/14 patients, P=0.032) and the difference was more pronounced when eutopic endometriums from patients with endometriosis were compared with those of healthy controls (2/30 patients, P<0.001). Aromatase-positive patients had more moderate-to-severe chronic pelvic pain, higher CA-125 level significantly. Also in operative findings, severe grade endometriosis, bilateral endometriomas, and associated leiomyoma and adenomyosis were more frequent in aromatase positive patients. High values of white blood cell count, erythrocyte sedimentation rate, CA 19-9 were more frequent in aromatase positive patients notwithstanding insignificant differences. CONCLUSION: Unopposed local biosynthesis of estrogens by increased expression of aromatase in eutopic endometrium and endometrial tissue could be involved in the development or maintenance of endometriosis and other uterine estrogen-triggered diseases. Our findings suggest increased expression of aromatase may be related with severity, activity, and chronic pelvic pain in patients with endometriosis.
Adenomyosis
;
Aromatase
;
Blood Sedimentation
;
Curettage
;
Endometriosis
;
Endometrium
;
Estrogens
;
Female
;
Humans
;
Immunohistochemistry
;
Laparoscopy
;
Leiomyoma
;
Leukocyte Count
;
Pelvic Pain
;
Steroids
;
Biomarkers, Tumor
6.A Clinical Study of Infiltrating Lobular Breast Cancer.
Jung Mo KIM ; Young Chul KIM ; Dong Young NOH ; Yeo Kyu YONG ; Seung Keun OH ; Kuk Jin CHOE
Journal of the Korean Cancer Association 1999;31(1):90-97
PURPOSE: Infiltrating lobular carcinoma of the breast was known to have a high incidence of multicentricity and bilaterality in patients. We analyzed the clinical features of infiltrating lobular breast cancer. MATERIALS AND METHODS: We studied 29 patients with infiltrating lobular carcinoma of the breast, from Jan. 1980 to Mar. 1997 in the Department of Surgery, Seoul National University Hospital. RESULTS: The age of the patients ranged from 32 to 71 years with an average of 45.2 years. The main complaining symptom was a painless mass. The diameter of the tumor ranged from 0.7 to 7 cm with a mean size of 2.8 cm. The axillary lymph node was positive for malignancy in 12 cases. The number of multicentric breast cancers were 7 cases (24.1%), and the number of bilateral breast cancers were 3 cases (10.3%). The estrogen receptor was positive in 66.7%, and the progesterone receptor was positive in 75% of the cases. There were one local recurrence and three distant metastases during a mean follow-up period of 4.5 years. The 5-year survival rate and 5-year disease free survival rate were 89.6% and 88.6%, respectively. CONCLUSION: Infiltrating lobular breast cancers are at greater risk of developing multicentricity and bilaterality than nonlobular breast cancers. Careful program of frequent follow-up examinations and thorough histopathological studies are needed for patients with infiltrating lobular breast cancers.
Breast Neoplasms*
;
Breast*
;
Carcinoma, Lobular
;
Disease-Free Survival
;
Estrogens
;
Follow-Up Studies
;
Humans
;
Incidence
;
Lymph Nodes
;
Neoplasm Metastasis
;
Receptors, Progesterone
;
Recurrence
;
Seoul
;
Survival Rate
7.Noninvasive Cardiovascular and Respiratory System Monitoring in Laparoscopic Cholesystectomy.
Gyu Jeong NOH ; Sang Yoon CHO ; Jong Hoon YEOM ; Woo Jong SHIN ; Yong Chul KIM ; Dong Ho LEE
Korean Journal of Anesthesiology 2000;39(3):303-308
BACKGROUND: The deleterious cardiopulmonary side effects immediately after positioning in reverse Trendelenburg and CO2 intra-abdominal insufflation during a laparoscopic cholecystectomy are well tolerated in healthy patients but can lead to serious morbidity and mortality in patients with a limited cardiopulmonary reserve. Using a continuous and non-invasive cardiac output monitor based on partial CO2 rebreathing method, we investigated the immediate cardiopulmonary changes caused by positioning in reverse Trendelenburg and CO2 intra-abdominal insufflation during a laparoscopic cholecystectomy, and assessed the applicability of the partial CO2 rebreathing method for the measurement of cardiac output in a laparoscopic cholecystectomy. METHODS: The investigation was carried out on 11 patients undergoing a laparoscopic cholesystectomy. The control values of cardiac index (CI), cardiac output (CO), mean arterial pressure (MAP), heart rate (HR), central venous pressure (CVP), systemic vascular resistance (SVR), dynamic compliance (Cdyn), airway resistance (Raw), peak inspiratory pressure (PIP) and end tidal CO2 partial pressure (PETCO2) were measured in the supine position after induction with target-controlled infusion of propofol (5 microgram/ ml). Five minutes after positioning in reverse Trendelenburg and CO2 insufflation, the same cardiopulmonay variables were measured and compared with the control values. RESULTS: CI, CO and CVP were reduced 33.3%, 31.9% and 29.0%, respectively (P < 0.05). MAP and SVR were increased 39.8% and 154.1%, respectively (P < 0.05). Cdyn was reduced 38.0% (P < 0.05). Raw and PIP were increased 22.8%, and 34.8%, respectively (P < 0.05), whereas HR and PETCO2 remained unchanged. CONCLUSIONS: The non-invasive cardiopulmonary monitor using partial CO2 rebreathing method, could be used with ease and safety in a laparoscopic cholecystectomy.
Airway Resistance
;
Arterial Pressure
;
Cardiac Output
;
Central Venous Pressure
;
Cholecystectomy, Laparoscopic
;
Compliance
;
Heart Rate
;
Humans
;
Insufflation
;
Mortality
;
Partial Pressure
;
Propofol
;
Respiratory System*
;
Supine Position
;
Vascular Resistance
8.Modeling of Recovery Profiles in Mentally Disabled and Intact Patients after Sevoflurane Anesthesia; A Pharmacodynamic Analysis.
Teo Jeon SHIN ; Gyu Jeong NOH ; Yong Seo KOO ; Dong Woo HAN
Yonsei Medical Journal 2014;55(6):1624-1630
PURPOSE: Mentally disabled patients show different recovery profiles compared to normal patients after general anesthesia. However, the relationship of dose-recovery profiles of mentally disabled patients has never been compared to that of normal patients. MATERIALS AND METHODS: Twenty patients (10 mentally disabled patients and 10 mentally intact patients) scheduled to dental surgery under general anesthesia was recruited. Sevoflurane was administered to maintain anesthesia during dental treatment. At the end of the surgery, sevoflurane was discontinued. End-tidal sevoflurane and recovery of consciousness (ROC) were recorded after sevoflurane discontinuation. The pharmacodynamic relation between the probability of ROC and end-tidal sevoflurane concentration was analyzed using NONMEM software (version VII). RESULTS: End-tidal sevoflurane concentration associated with 50% probability of ROC (C50) and gamma value were lower in the mentally disabled patients (C50=0.37 vol %, gamma=16.5 in mentally intact patients, C50=0.19 vol %, gamma=4.58 in mentally disabled patients). Mentality was a significant covariate of C50 for ROC and gamma value to pharmacodynamic model. CONCLUSION: A sigmoid Emanx model explains the pharmacodynamic relationship between end-tidal sevoflurane concentration and ROC. Mentally disabled patients may recover slower from anesthesia at lower sevoflurane concentration at ROC an compared to normal patients.
*Anesthesia Recovery Period
;
Anesthesia, Dental/*methods
;
Anesthesia, General/*methods
;
Anesthetics, Inhalation/*administration & dosage/pharmacology
;
Case-Control Studies
;
Child
;
Child, Preschool
;
Consciousness/drug effects
;
Dental Care for Disabled/*methods
;
Dose-Response Relationship, Drug
;
Female
;
Humans
;
Male
;
Mentally Disabled Persons
;
Methyl Ethers/*administration & dosage/pharmacology
9.A Case of Pelvic and Abdominal Actonomycosis Associated with an Intrauterine Contraceptive.
Yeon Ju LIM ; Byung Cheol KIM ; Hyun Ju NOH ; Chel Woo LEE ; Un Jeong HWANG ; Yong Duk SHIN ; Dong Jin KIM
Korean Journal of Obstetrics and Gynecology 1999;42(1):208-213
Actinomycosis is a rare entity which presents some difficulties in establishing a correct preoperative diagnosis. Many actinomycotic pelvic infections in women are related to IUD use and the colonization rate appears to increase in accordance with the duration of IUD use. So, all women in IUD use are recommended to make cervicovaginal smear and pelvic infection associated with IUD use should be suspected to have actinomycoses. We report a case which presented painful mass on right upper and lower quadrant of abdomen of a 40-year-old women. We identified sulfur granules by histopathologic exam of surgically resected specimen. Eventually it proved to be pelvic and abdominal actinomycosis associated with the use of an intrauterine device. Because variable clinical pictures and infrequency of the disease make the diagnosis more difficult, increased alertness of clinicians and microbiologists to the presence of anaerobic organism as the cause of infection are needed to make an earlier and more correct diagnosis of actinomycoses and to further avoid any inappropriate treatment.
Abdomen
;
Actinomycosis
;
Adult
;
Colon
;
Diagnosis
;
Female
;
Humans
;
Intrauterine Devices
;
Pelvic Infection
;
Pelvis
;
Sulfur
10.Care Pathway for Cancer Survivorship in Korea: Trend of Breast Cancer Pathway from 2003 to 2010.
Healthcare Informatics Research 2017;23(2):119-125
OBJECTIVES: The survival rate of cancer patients has exceeded 60%. Although cancer survivors may die of other diseases except cancer, the health management system including chronic disease prevention-management for cancer survivors, has not been established in the diverse aspects. Therefore, services according to care pathway of cancer patients need to be provided through a support system based on a platform concept that can be used to meet patient needs in various ways. METHODS: A sample cohort database (2002–2010) of approximately 1 million persons—2% of the whole nation (50 million)—was used to estimate cancer survivors through a principal care pathway for cancer management. The sample cohort database was built to estimate the number of breast cancer survivors in the five stage: ‘Diagnosis and treatment,’‘Supportive care,’‘Monitoring,’‘Progress illness,’ and ‘Hospice care’. In this way, the scale of breast cancer survivors was estimated. RESULTS: There were 330 (9.8%) cases of the incidence of cancer in 2010 in the ‘Diagnosis and treatment.’ Among the cases of the incidence of cancer in the previous year, the number of one-year survivors was 328 (9.7%); these were included in the category ‘Supportive care.’ In the ‘Monitoring’ category, 2,593 (76.9%) who maintained health lives were included. A total of 84 (2.5%) survivors were checked to identify an ongoing disease; these were included in the category ‘Progress illness.’ In the category ‘Hospice care,’ 36 (1.1%) end-stage cancer patients requiring hospice care were included. CONCLUSIONS: We established a care pathway by survival stage in order to fulfill prevention and health management services post-treatment management steps.
Breast Neoplasms*
;
Breast*
;
Chronic Disease
;
Cohort Studies
;
Critical Pathways
;
Hospice Care
;
Humans
;
Incidence
;
Korea*
;
Postoperative Care
;
Survival Rate*
;
Survivors